Improving Patient Communication on LASIK Benefits and Risks

In an effort to ensure that the benefits and risks of laser-assisted in situ keratomileusis (LASIK) are clearly communicated to patients, the FDA has drafted guidance detailing proposed recommendations for the content and format of patient labeling for LASIK devices, according to an agency statement. The nonbinding draft is open for comment through October 26.
Source: JAMA - Category: General Medicine Source Type: research